The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Mixed Despite US-China Trade Deal Optimism

Tue, 08th Jan 2019 08:58

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in Beijing.

The second day of negotiations coincided with an unannounced visit by North Korean leader Kim Jong Un, with some analysts saying China could use Kim's visit as a bargaining chip in the US trade talks.

China's Shanghai Composite index slid 0.26% to 2,526.46 while Hong Kong's Hang Seng index rose 0.15% to 25,875.45.

Japanese shares ended on a positive note after Amazon and Microsoft Corp fueled a second straight session of gains on Wall Street overnight.

The Nikkei average gained 165.07 points or 0.82% to finish at 20,204.04 while the broader Topix index closed 0.39% higher at 1,518.43.

Automaker Honda Motor rallied 3.2% and Toyota rose 1.2% while banks Mitsubishi UFJ Financial, Sumitomo Mitsui Financial and Mizuho Financial rose between 0.3% and 1.3%.

Takeda Pharmaceutical climbed 2.3% after completing its acquisition of Irish drugmaker Shire. Inpex and Japan Petroleum gained around 1% after crude oil prices rose more than 1% overnight.

Olympus Corp jumped 8.4% after Morgan Stanley upgraded the stock's rating to "overweight" from "equal-weight".

Seoul stocks fell as investors monitored the second day of trade talks between China and the US. The benchmark Kospi dropped 11.83 points or 0.58% to 2,025.27. Samsung Electronics lost 1.7% after it partnered with tech giant Apple Inc. to bring iTunes content to Samsung smart televisions.

On the data front, South Korea posted a current account surplus of USD5.06 billion in November, the Bank of Korea said - down from the USD9.19 billion surplus in October. The goods account surplus stood at USD7.97 billion, down from USD11.46 billion in November 2017.

Australian markets closed notably higher amid signs that Beijing and Washington may be inching closer toward a trade deal.

Traders shrugged off weak trade data showing that the country had a seasonally adjusted merchandise trade surplus of AUD1.925 billion in November, shy of expectations for a surplus of AUD2.175 billion and down from AUD2.316 billion in October.

The benchmark S&P/ASX 200 index rose 39.20 points or 0.69% to 5,722.40 while the broader All Ordinaries index ended higher by 38.80 points or 0.68% at 5,783.30.

Banks ANZ, NAB and Westpac rose between 0.9% and 1.2%. Waste management giant Bingo Industries soared 5.7% after it offered to sell its Sydney processing plant to address antitrust concerns related to the planned acquisition of Dial-aDump.

Gold miner Evolution lost 3.4%, St Barbara tumbled 5% and Northern Star Resources declined 2.6% as dovish comments from the Fed boosted investors' appetite for risk.

Sleep device maker ResMed advanced 1.4% after completing the USD225 million acquisition of US-based asthma and pulmonary specialist Propeller Health.

New Zealand shares rose modestly, with the benchmark S&P/NZX 50 index finishing up 15.11 points or 0.17% at 8,821.15.

U.S stocks rose overnight as the US and China resumed talks on their trade war and Federal Reserve Chair Jerome Powell said the central bank would be "flexible" in its approach to monetary policy.

The Dow Jones Industrial Average rose 0.4%, the tech-heavy Nasdaq Composite rallied 1.3% and the S&P 500 climbed 0.7%.

More News
25 Oct 2018 15:20

TOP NEWS: Shire Seeks US Approval To Make Flexbumin At New Facility

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Thursday said it has filed a submission to the US Food & Drug Administration for approval to manufacture Flexbumin at its new is as

Read more
23 Oct 2018 16:25

MOVES-JPMorgan reshuffles healthcare group, co-head departs -sources

By Greg Roumeliotis and Liana B. Baker Oct 23 (Reuters) - JPMorgan Chase & Co has appointed Mike Gaito as global co-head of healthcare investment banking after Jeff Stute, who held that

Read more
19 Oct 2018 14:38

Shire's lanadelumab gets one step closer to European approval

(Sharecast News) - Rare disease-focussed biotechnology company Shire announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing authorisation of 'lanadelumab' injection, for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.

Read more
18 Oct 2018 09:26

UPDATE 1-Takeda gets Japanese approval for $62 bln Shire purchase

Oct 18 (Reuters) - Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the Japanese firm closer to a it

Read more
1 Oct 2018 11:24

Schroder Japan Growth Outperforms Benchmark In Full Year

LONDON (Alliance News) - Schroder Japan Growth Fund PLC said on Monday it outperformed its benchmark in its recently ended financial year due to a robust performance in the first half, in spite of

Read more
28 Sep 2018 06:23

UK Stocks-Factors to watch on Sept 28

Sept 28 (Reuters) - Britain's FTSE 100 index is seen opening 8 points higher at 7,553 on Friday, according to financial bookmakers. * SHIRE: Japan M&A volumes are set to break a 19-year-old

Read more
28 Sep 2018 04:09

Morning News Call - India, September 28

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_09282018.pdf If you would like to receive this newsletter via email, please at: TO

Read more
27 Sep 2018 17:53

UPDATE 1-FTSE rises to 4-week high helped by sterling weakness

* FTSE 100 up 0.5 pct * Higher crude lifts oil stocks, hits airlines * TUI sticks to forecasts, shares gain (Adds details, closing prices) By Danilo Masoni MILAN, Sept

Read more
21 Sep 2018 11:26

Shire Gets Japanese Approval For Rare Genetic Disease Drug Firazyr

LONDON (Alliance News) - Pharmaceutical company Shire PLC on Friday said it has been granted manufacturing and marketing authorisation in Japan for its hereditary angioedema drug, Japanese of has

Read more
21 Sep 2018 07:19

Shire gets approval for hereditary angioedema treatment in Japan

(Sharecast News) - Rare disease specialist Shire announced on Friday that the Ministry of Health, Labour and Welfare (MHLW) in Japan has granted manufacturing and marketing authorisation for its 'FIRAZYR' icatibant injection, for the acute treatment of hereditary angioedema (HAE) attacks in adult patients with HAE.

Read more
17 Sep 2018 06:41

UK Stocks-Factors to watch on Sept 17

Britain's FTSE 100 index is seen opening 11 points lower at 7,293 on Monday, according to financial bookmakers. * GOLD: Gold inched up on Monday as bargain-hunters bought the metal after prices

Read more
14 Sep 2018 17:28

UPDATE 1-FTSE tracks Europe higher; Shire shines

* FTSE 100 up 0.3 pct * Shire gains after China nod to Takeda deal * Housebuilders in focus * Investec rallies on spin-off plans (Adds closing) By Danilo Sept 14 - top

Read more
14 Sep 2018 12:01

LONDON MARKET MIDDAY: Stocks Higher As Shire And Whitbread Gain

LONDON (Alliance News) - Stocks in London were higher at midday on Friday with Shire and Whitbread performing well among FTSE 100 constituents, while in the FTSE was

Read more
14 Sep 2018 10:32

WINNERS & LOSERS SUMMARY: Housebuilders Hit By No-Deal Brexit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - up 1.8%. Takeda Pharmaceutical said it had in of

Read more
14 Sep 2018 10:16

FTSE tracks Europe higher on trade hopes; Shire shines

(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 up 0.1 pct * Shire gains after China nod to Takeda deal * Housebuilders under Investec on -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.